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A new in vitro model for stem cell differentiation
and interaction
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d Interuniversity Cardiology Institute of the Netherlands, Utrecht, The NetherlandsReceived 30 September 2008; received in revised form 24 October 2008; accepted 27 October 2008Abstract Development involves an interplay between various cell types from their birth to their disappearance by
differentiation, migration, or death. Analyzing these interactions provides insights into their roles during the formation of
a new organism. As a study tool for these interactions, we have created a model based on embryoid bodies (EBs) generated
from mouse embryonic stem (mES) cells, which can be used to visualize the differentiation of mES cells into specific cell
types while at the same time allowing controlled removal of this same cell population using an enzyme–prodrug approach.
Cell-specific expression of Cre induces a switch of EGFP expression to LacZ. Furthermore, it leads to the expression of
nitroreductase (NTR), which in combination with the prodrug CB1954 induces apoptosis. Here, we validate this model by
showing expression of LacZ and NTR after Cre-mediated recombination. Additionally we show, as an example, that we can
target the endothelial cells in EBs using the Tie-2 promoter driving Cre. Ablating Cre-expressing cells by adding CB1954 to the
culture led to an abrogated vascular formation. This system can easily be adapted to determine the fate and interaction of
many different cell types provided that there is a cell-type-specific promoter available.
© 2008 Elsevier B.V. All rights reserved.Introduction
Embryonic development involves a dynamic interplay
between various progenitor cell populations, their diffe-
rentiated progeny, and adjacent neighbors to generate a
living organism. Embryonic stem (ES) cell-derived embryoid
bodies (EBs) resemble the postimplantation egg-cylinder-
stage embryo and provide an in vitro model to study
differentiation during early development (Doetschman
et al., 1985). For example, vascular development within⁎ Corresponding author. Fax: +31 71 526 8270.
E-mail address: m.j.goumans@lumc.nl (M.-J. Goumans).
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doi:10.1016/j.scr.2008.10.002EBs follows an orderly sequence of events that recapitulates
vasculogenesis in vivo (Vittet et al., 1996). When cultured in
a collagen I matrix, EBs develop a network of branching
endothelial cell outgrowths that are covered with pericytes,
thus constituting a valuable model for studying angiogenesis
(Feraud et al., 2001).
To study the differentiation and interaction of cells during
development we have designed a model to target a specific
cell type within the EB, allowing us to visualize the
differentiation into a specified cell type and determine its
contribution to development by selective ablation.
A constitutively active promoter drives the expression of
enhanced green fluorescent protein (EGFP). After Cre-
mediated excision, EGFP is replaced by nitroreductase (NTR).
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the reduction of nitrogroups into hydroxylamine in the
presence of NADH or NAD(P)H. NTR can metabolize the
prodrug CB1954 into an alkylating agent that cross-links DNA,
resulting in apoptosis (Cui et al., 1999). This thereby acts as an
inducible ablation system. Previously, NTR has been reported
as an option for gene-directed enzyme–prodrug therapy in
patients (Bridgewater et al., 1995).
Furthermore, the LacZ gene allows visualization of Cre-
expressing (and thus NTR-expressing) cells. By placing Cre
under control of a cell-type-specific promoter, we can target
a specific population of cells, and the time point at which
this population appears can be investigated. In this report we
validate this system and show as an example the result of
targeting endothelial cells in EBs.
Results and discussion
To generate an inducible ablation system, the ActENIL
expression construct (Fig. 1A) was stably transfected into
mouse ES (mES) cells, and hygromycin-resistant, EGFP-
expressing clones were selected. To analyze the effects of
Cre-mediated recombination, the CMV-Cre plasmid was
transfected into the ActENIL-harboring mES lines (ActENIL+
Cre). Flow-cytometric analysis confirmed that ActENIL mES
cells were EGFP positive and that this expression was lost
after Cre-mediated recombination (Fig. 1B). Additionally,
ActENIL+Cre mES cells expressed β-galactosidase, which
was not present in the ActENIL mES cells (Fig. 1C).
To confirm the expression and activity of NTR, cells were
incubated with CytoCy5S, which is a quenched fluorescent
substrate that is converted by NTR into a red fluorescent dye.
Although the IB10 (wild-type cells) and ActENIL cell linesFigure 1 Characteristics of ActENIL mES cells. (A) Structure of
the ActENIL construct containing aβ-actin promoter, a floxed EGFP-
Stop cassette, NTR, and IRES-LacZ. (B) Flow-cytometric analysis of
EGFP expression in the IB10, ActENIL, and ActENIL+ Cre mES cells.
(C) X-gal staining of ActENIL (left) and ActENIL+ Cre (right) cells
shows LacZ expression after Cre excision.show a shift in red fluorescence background when CytoCy5S
is added, the ActENIL+Cre cells reveal a highly red
fluorescent population, indicating NTR activity (Fig. 2A).
Next, the effect of CB1954 in culture was determined by
incubating ActENIL and ActENIL+Cre cells with various
concentrations of CB1954 for 3 days. MTT assay showed
that the ActENIL+Cre cell line was indeed more sensitive to
CB1954 treatment than ActENIL cells (LD50 approximately
2 μM versus 20 μM, respectively, Fig. 2B). In the untrans-
fected cells, cell death also occurs, but at higher concentra-
tions of CB1954. Cell death due to CB1954 has been described
for other cell types as well: adipocytes (Felmer and Clark,
2004), SKOV3 (Palmer et al., 2003), and 3T3 cells (Bridge-
water et al., 1995). Since at high concentrations CB1954 may
also induce necrosis (Palmer et al., 2003), we chose a
concentration of 10 μM CB1954, which shows cell death in
the CMV-Cre targeted cells, while little effect is seen in the
nontargeted cells. When incubating cells with a concentra-
tion of 10 μM CB1954 for 1 day, we found that the number of
EGFP+ cells remained unaffected in the ActENIL cell line,
while the contribution of EGFP+ cells in the ActENIL+Cre line
became higher, demonstrating that CB1954 kills the NTR/
LacZ+ cells while leaving the EGFP+ cell population intact
(Fig. 2C).
To confirm ablation of a specific cell population in this
system, we chose to target the endothelial cell. After stable
transfection of Tie2-Cre into the ActENIL cell line (ActENIL+
T2-Cre), the mES cells were differentiated as EBs using the
hanging drop method. The EBs were then grown in collagen
matrix to induce the formation of sprouts. After 15 days of
aggregation we found that LacZ+ sprouts had arisen from the
ActENIL+T2-Cre EBs (Fig. 3A). Furthermore, endothelial
sprouts were positive for Cre recombinase (Fig. 3B). Next,
the effect of removal of endothelial cells on sprouting was
assessed by adding CB1954 to the collagen matrix. Three
categories of EBs were observed, strong sprouting (Fig. 3C),
small sprouts on only a minor fraction of the EBs (Fig. 3D),
and no sprouting (Fig. 3E). The CB1954 did not affect
sprouting of EBs generated from the IB10 or the ActENIL mES
cells (Fig. 3F); there were no differences in the percentages
of nonsprouting or small-sprouting EBs in either group. In the
ActENIL+T2-Cre cells the number of sprouting EBs without
CB1954 treatment was similar to that of ActENIL EBs.
However, when CB1954 was present, the percentage of
nonsprouting EBs increased with increasing concentration of
CB1954.
PECAM staining confirmed that in the presence of 10 μM
CB1954 the sprouting in the ActENIL cells was unaffected,
while sprouting was abrogated in the ActENIL+T2-Cre EBs
(Figs. 4A–D). To quantify this effect the average sprout
length in the different groups of EBs was measured. This
revealed that the average sprout length in the IB10-derived
EBs was unaffected when incubated with CB1954 (Fig. 4D). A
minor effect was observed on ActENIL EBs, which could be a
consequence of background toxicity of the CB1954. However,
the effect of CB1954 treatment on ActENIL+T2-Cre sprouting
was significantly affected by CB1954 incubation, leading to
no or very short sprouts (Fig. 4D). These data confirm that we
can specifically identify and ablate endothelial cells thereby
affecting the development of vascular sprouts.
This system has been generated to provide a flexible and
easy method to identify specific cell populations and
Figure 2 NTR expression and sensitivity to CB1954. (A) Flow-cytometric analysis of NTR enzyme activity. The quenched CytoCy5S is
converted into a red fluorescent dye by NTR. The top shows controls, the bottom, the CytoCy5S-incubated cells. (B) The sensitivity of
ActENIL and ActENIL+Cre cells to CB1954 determined by MTTassay. Means±SEM. (C) Percentage of EGFP+ cells in the presence of 10 μM
CB9154 in the ActENIL and ActENIL+Cre cell lines, determined by flow cytometry (representative graph).
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the desired cells harbor a cell-type-specific promoter that
can be coupled to Cre, this population can be targeted by
stably transfecting the Cre plasmid into the mES ActENIL
cell line.
Furthermore, this ablation model can provide an
important tool for determining the interaction between
specific cell types, as it is possible to remove one cell from
the system at any given time by the addition of CB1954,
leaving non-Cre-expressing cells alive. Recently a similar
ablation model was reported using diphtheria toxin on cell-
type-specific Cre expression (Wu et al., 2006). Although
diphtheria-toxin-induced cell death is comparable to the
NTR/CB1954 system, our model has the advantage of
temporal regulation of target cell ablation by the addition
of CB1954. Many different cell types have been detected in
EBs. These include cardiomyocytes (Maltsev et al., 1993),
motor neurons (Soundararajan et al., 2006), and kidney-
derived cell types such as glomerular podocytes and renaldistal tubule epithelial cells (Kramer et al., 2006),
providing an almost unlimited potential for studying
differentiation and cellular interaction. As future applica-
tions, one can, for example, consider using this model to
screen compounds or small molecules for their effects on
cell-type-specific differentiation. Furthermore, the
embryonic stem cells generated in this study were used
to generate an in vivo mouse model for cell ablation.Material and methods
The ActENIL construct (±14 kb) was generated using pCAG as
a backbone, which contains a modified chicken actin
promoter, poly(A) sequence, and hygromycin-resistance
gene. An EGFP–lox–Stop cassette, NTR (obtained from
CMV-NTR), and an IRES–LacZ cassette (isolated from
pGT1.8IresBgeo) were cloned into pCAG. The ActENIL
construct was linearized using AhdI.
Figure 3 Endothelial sprouting. (A) LacZ+ sprout in the
ActENIL+Tie2-Cre cells grown in collagen. (B) Cre expression in
sprouts of ActENIL+Tie-2 EBs; Cre in red. (C) Sprouting EB; (D)
intermediate sprouting EB with arrow indicating sprouts; (E)
nonsprouting EB. (F) The percentages of nonsprouting (black),
intermediate-sprouting (white), and sprouting (gray) EBs incu-
bated with 0, 5, or 10 μM CB1954 are shown. (Representative
graph of three independent experiments.)
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inserting the Tie-2 promoter (obtained from PGL3-Tie2; Dube
et al., 1999) and Cre (derived from pCAGGS) into pBS.
IB10 mES cells were cultured under feeder-free condi-
tions on gelatin-coated dishes in Buffalo rat liver cell
conditioned medium (BRL-CM) as described previously
(Mummery et al., 1990). The ActENIL plasmid was electro-
porated into mES cells, which were subsequently placed
under hygromycin selection. Surviving clones were cultured
separately in BRL-CM.
To determine the characteristics of the model, ActENIL-
harboring cells were stably transfected with CMV-Cre
(pCAGGS) or Tie-2-Cre.
Flow-cytometric analysis was performed using a Cytomics
FC500 (Beckman Coulter) to determine EGFP expression. The
activity of NTR was determined by incubating cells with 1 μM
CytoCy5S (GE-Healthcare) for 3 h prior to measuring red
fluorescence.
To determine the sensitivity mES cell lines to CB1954, cell
survival was measured by MTT assay at various concentra-
tions of CB1954 as described previously (Mosmann, 1983).
Each measurement was carried out in triplicate and eachcondition at least in duplicate. Cell viability was calculated
relative to untreated cells.
EBs were generated using hanging drops as described
previously (Slager et al., 1993) in DM (Dulbecco’s modified
Eagle’s medium supplemented with 2 mM l-glutamine,
nonessential amino acids, 20% FCS, β-mercaptoethanol,
50 ng/ml VEGF (Sigma), and 25 ng/ml bFGF (Sigma)). After
2 days, EBs were transferred to ultra-low-attachment dishes
(Corning) and grown in suspension for 7 days. To induce
sprouting, EBs were placed in a collagen matrix containing
0.8 mg/ml rat collagen I (Roche) in DM (Feraud et al., 2001).
CB1954 was added to the collagen matrix as required.
To visualize endothelial cells and Cre recombinase,
collagen matrices were mounted on glass microscope slides
as described (Feraud et al., 2001). EBs were fixed in IHC zinc
fixative (BD Biosciences) and stained with anti-mouse PECAM
(BD PharMingen) or anti-Cre (Novagen), Alexa Fluor 555 goat
anti-mouse or anti-rabbit (Invitrogen), and Hoechst (Invitro-
gen). For LacZ staining, cells were fixed in 1% formaldehyde,
0.2% glutaraldehyde, and 0.02% NP-40. β-Galactosidase
activity was visualized by incubating cells with 1 mg/ml X-
gal, 5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, and 2 mM MgCl2.
Sprouting was indexed as nonsprouting, intermediate
sprouts, and sprouting. The latter is characterized by
extensive sprouting around the whole circumference of the
EB. Sprout length was measured on PECAM-stained EBs using
Angioquant, and the average length was determined for
eight EBs per condition.
Statistical significance was evaluated using ANOVA (with
Bonferroni correction for multiple-group comparisons) or
Mann–Whitney U test, as applicable. Results are expressed
as means±SEM. A value of p≤0.05 was considered statisti-
cally significant.
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